首页> 中文期刊> 《中国生化药物杂志》 >枸橼酸莫沙必利在反流性食管炎治疗与干预效果分析

枸橼酸莫沙必利在反流性食管炎治疗与干预效果分析

         

摘要

Objective To explore the use of mosapride citrate in treating reflux esophagitis and nursing intervention spitley effect. Methods In 40 cases of reflux esophagitis in patients with routine therapy, and classified as the control group, the other 40 patients in the control group based on the use of mosapride citrate. And classified as the observation group, two groups of patients were in our hospital from June 2015 to January 2017. Results The study in the treatment of the two groups of patients with effective rate of 95.0%, the observation group was significantly higher than the control group 80.0%, between the two groups showed significant differences (P<0.05). The adverse effects of more than two groups found, two groups of patients with adverse reaction incidence was no significant difference, that shows no significant difference. Conclusion Mosapride citrate in reflux esophagitis treatment and intervention effect analysis found that the compared with conventional therapy, can be in At the same time, it can improve the curative effect of the patients, and will not increase the possibility of adverse reactions, so it is worthy of clinical reference.%目的 探究在反流性食管炎治疗和护理干预时使用枸橼酸莫沙必利的效果.方法 针对40例反流性食管炎患者使用常规治疗,并归为对照组,针对另外40例患者在对照组基础上使用枸橼酸莫沙必利,并归为观察组,2组患者均为本院2015年6月~2017年1月间收治.结果 就本次研究中2组患者的治疗有效率而言,观察组的95.0%明显高于对照组的80.0%,2组比较差异具有统计学意义(P<0.05).比较2组患者的不良反应情况,发现2组患者的不良反应发生率比较差异无统计学意义.结论 枸橼酸莫沙必利在反流性食管炎治疗与干预效果分析发现,其相比常规的治疗而言,能够在用药的同时提高患者治疗效果,且不会增加患者出现不良反应的可能,因此值得临床借鉴.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号